Please assess the completion status of the following clinical trial:

Trial Title: Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Age \>= 18 years with diabetic macular edema~* Diagnosis of diabetes mellitus types 1 or 2~* Best corrected visual acuity of 19-68 letters~* Retinal thickness \> 250 micron by OCT~* Investigator is comfortable deferring macular laser treatment for 6 weeks~Exclusion Criteria:~* Glaucoma, ocular hypertension, IOP \>21 mmHg or concurrent therapy at screening with IOP lowering agents~* Retinal or choroidal neovascularization due to ocular conditions other than diabetic retinopathy~* Prior intravitreal, subtenon, or periocular steroid therapy within 6 months~* Any ocular surgery within the last 3 months~* Retinal laser treatment within the last 3 months~* History of uncontrolled IOP elevation with steroid use that did not respond to topical therapy~* Any lens opacity which impairs visualization of the posterior pole

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: EXPERIMENTAL): None
- 3 (Type: SHAM_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).